14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WOK vs TDIC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, WORK Medical Technology Group LTD Class A (WOK) is the stronger overall head-to-head candidate over Dreamland Limited Class A (TDIC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas TDIC carries 42.6/100 (HOLD) at $1.44 (N/M Forward P/E, -124.2% operating margin).
Composite vs. Pillar Nuance: While TDIC currently prints a higher short-term Unified Composite Score (42.6/100 HOLD vs. WOK 25.6/100 SELL), WOK captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-41.7% vs. -124.2% operating margin) and revenue trajectory (+19.1% vs. -27.5% YoY).
Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile TDIC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs TDIC. Trailing 12-month operating profitability (WOK -41.7% vs TDIC -124.2%) and valuation multiples (WOK N/M vs TDIC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Advertising Agencies value chain with $5.3M market capitalization and -124.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ WOK vs TDIC Key Questions & Quantitative Answers
As of Nov 16, 2026, WORK Medical Technology Group LTD Class A (WOK) is the stronger overall head-to-head candidate over Dreamland Limited Class A (TDIC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas TDIC carries 42.6/100 (HOLD) at $1.44 (N/M Forward P/E, -124.2% operating margin). Composite vs. Pillar Nuance: While TDIC currently prints a higher short-term Unified Composite Score (42.6/100 HOLD vs. WOK 25.6/100 SELL), WOK captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-41.7% vs. -124.2% operating margin) and revenue trajectory (+19.1% vs. -27.5% YoY). Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile TDIC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TDIC leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with TDIC at -27.5% YoY revenue growth and -35.2% YoY earnings growth on $51M TTM revenue (0.9% gross margin, -124.2% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $51M for TDIC. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TDIC.
TDIC screens cheaper on headline valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas TDIC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-124.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus TDIC (-1012.1% ROE) capital efficiency.
In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, TDIC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (28.22β · 76% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.